Zurich Cantonal Bank’s NextCure NXTC Stock Holding History

Zurich Cantonal Bank’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-29	Closed	-$4K	–	2613
2021 Q1	$4K	Sell	29 -1,608	-98%	-$233K	﹤0.01%	2547
2020 Q4	$214K	Hold	1,637	–	–	﹤0.01%	1800
2020 Q3	$173K	Buy	+1,637	New	+$201K	﹤0.01%	1708

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Zurich Cantonal Bank's NXTC Position: Q2 2021 in Review

Zurich Cantonal Bank sold out of NextCure (NXTC) in Q2 2021, closing a stake of 29 shares — an estimated $4K sold.

Zurich Cantonal Bank first reported a position in NXTC in Q3 2020 and held it in 3 quarters. The position peaked at $214K in Q4 2020. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

Zurich Cantonal Bank reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
Zurich Cantonal Bank sold 29 NextCure shares in Q2 2021, an estimated $4K.
Zurich Cantonal Bank first reported a position in NextCure in Q3 2020 and held it in 3 quarters.
Zurich Cantonal Bank's NextCure position peaked at $214K in Q4 2020.
78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Zurich Cantonal Bank's 13F filing for Q2 2021, filed 30 Jul 2021.